ArTS Archivio della ricerca di Trieste

LASSIANI, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.572
EU - Europa 1.963
AS - Asia 1.746
SA - Sud America 176
AF - Africa 89
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.561
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.548
SG - Singapore 612
CN - Cina 477
PL - Polonia 419
SE - Svezia 313
IT - Italia 283
UA - Ucraina 259
VN - Vietnam 176
HK - Hong Kong 158
FR - Francia 134
BR - Brasile 128
DE - Germania 122
KR - Corea 118
FI - Finlandia 108
RU - Federazione Russa 77
GB - Regno Unito 75
TR - Turchia 58
IE - Irlanda 44
BG - Bulgaria 40
IN - India 37
MA - Marocco 33
SN - Senegal 30
NL - Olanda 21
BE - Belgio 18
AR - Argentina 17
BD - Bangladesh 17
JP - Giappone 16
CA - Canada 13
AU - Australia 10
IQ - Iraq 10
EC - Ecuador 9
ES - Italia 9
ID - Indonesia 9
HR - Croazia 7
MX - Messico 7
SA - Arabia Saudita 7
ZA - Sudafrica 7
CH - Svizzera 6
IL - Israele 6
JO - Giordania 6
LT - Lituania 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
PK - Pakistan 5
CO - Colombia 4
ET - Etiopia 4
KE - Kenya 4
PY - Paraguay 4
DZ - Algeria 3
EU - Europa 3
LB - Libano 3
PE - Perù 3
RO - Romania 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
BO - Bolivia 2
BS - Bahamas 2
CI - Costa d'Avorio 2
CL - Cile 2
GA - Gabon 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
TH - Thailandia 2
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GH - Ghana 1
GR - Grecia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TN - Tunisia 1
TW - Taiwan 1
UG - Uganda 1
UY - Uruguay 1
Totale 7.561
Salva come PNG Salva come JPEG
Città #
Ann Arbor 518
Singapore 379
Warsaw 378
Woodbridge 378
Ashburn 258
Chandler 258
Houston 241
Jacksonville 225
Fairfield 212
San Jose 178
Hong Kong 152
Wilmington 145
Beijing 133
Hefei 112
Seoul 112
Trieste 94
Seattle 93
Princeton 80
Cambridge 76
Boardman 65
Columbus 54
Chicago 50
Santa Clara 50
Izmir 49
Ho Chi Minh City 48
Dublin 44
Lauterbourg 43
Los Angeles 42
Sofia 40
Hanoi 38
Zgierz 36
Dallas 32
Moscow 32
Casablanca 31
Dakar 30
Munich 29
The Dalles 28
Buffalo 27
Düsseldorf 27
Milan 26
Bremen 25
Frankfurt am Main 22
Turku 19
Brussels 18
San Diego 17
Dearborn 16
New York 16
Helsinki 15
London 15
Shanghai 14
São Paulo 14
Tokyo 14
Orem 11
Phoenix 10
Brooklyn 9
Guangzhou 9
Nanjing 9
Norwalk 9
Da Nang 8
Falls Church 8
Foligno 8
Kunming 8
Mestre 8
Mumbai 8
Padova 8
Roubaix 8
Tianjin 8
Shenyang 7
Des Moines 6
North Bergen 6
Nuremberg 6
Redondo Beach 6
San Francisco 6
Verona 6
Amman 5
Atlanta 5
Curitiba 5
Haiphong 5
Jinan 5
Philadelphia 5
Rio de Janeiro 5
St Petersburg 5
Sydney 5
Addis Ababa 4
Baghdad 4
Biên Hòa 4
Bologna 4
Chennai 4
Council Bluffs 4
Dhaka 4
Dong Ket 4
Fuzhou 4
Jiaxing 4
Johannesburg 4
Kocaeli 4
Nairobi 4
Purwokerto 4
Quito 4
Riyadh 4
Santo André 4
Totale 5.333
Salva come PNG Salva come JPEG
Nome #
Improving Biopharmaceutical Properties of Vinpocetine Through Cocrystallization 414
Rapidly-Disintegrating Laminar Extrudates: Preliminary Experiments upon an Age Appropriate Pediatric Formulation 397
New Anthranilic Acid Based Antagonists with High Affinity and Selectivity for the Human Cholecystokinin Receptor 1 (hCCK1-R) 292
Anthranilic acid derivatives: A new class of non-peptide CCK1 receptor antagonists 249
Chemical probes for the adenosine receptors 233
C-terminal anthranoyl-anthranilic acid derivatives and their evaluation on CCK receptors. 232
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 231
Synthesis of N-terminal substituted anthranilic acid dimer derivatives for evaluation on CCK receptors. 226
ANTHRANILIC ACID BASED CCK1 RECEPTOR ANTAGONISTS AND CCK-8 HAVE A COMMON STEP IN THEIR "RECEPTOR DESMODYNAMIC PROCESSES" 220
Synthesis and antitumor activity of α-alkyliden-γ-lactones 219
Anthranilic acid based CCK1 receptor antagonists: Blocking the receptor with the same ‘words’ of the endogenous ligand 217
Antiinflammatory action of hydrosoluble dimethyltriazenes on the carrageenin-induced edema in guinea pigs 217
Chemometric investigation of antitumor tests 215
Anthranilic acid based CCK1 antagonists: the 2-indole moiety may represent a “needle” according to the recent homonymous concept. 210
Anthranyl derivatives having an anticholecystokinin activity (anti-CCK1), a process for their preparation, and pharmaceutical use thereof 206
Anthranilic acid based CCK1 receptor antagonists 199
N-TERMINAL ANTHRANOYL-PHENYLALANINE DERIVATIVES AS CCK1 RECEPTOR ANTAGONISTS: THE FINAL APPROACH 197
Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes 195
Effect of High Hydrostatic Pressare on Cathalytic Behaviour of Pseudomonas Lipase 192
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 190
Kinetic study of the hydrolysis of 1-(4-nitrophenyl)-3-methyltriazene in aqueous solution and in the presence of surfactants 188
2D-QSAR and 3D-QSAR/CoMFA analyses of the N-terminal substituted anthranilic acid based CCK1 receptor antagonists: ‘Hic Rhodus, hic saltus’ 183
Anthranoyl-anthranilic acid: A template for the development of a new class of cholecystokinin receptor ligands. 181
Anthranyl derivatives having an anticholecystokinin activity (anti-CCK1), a process for their preparation, and pharmaceutical use thereof. 177
Effects of isomeric aryldimethyl-triazenes on Lewis lung carcinoma growth and metastases in mice 175
TWENTY YEARS OF NON-PEPTIDE CCK1 RECEPTOR ANTAGONISTS: ALL THAT GLITTERS IS NOT GOLD 168
Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma 164
Anthranilic Acid Based CCK1 Receptor Antagonists: Preliminary Investigation On Their Second “Touch point” 160
Kinetic investigation of the aqueous stability and antitumor activity of a hydrosoluble diaryltriazene, AVIS, related to the antimetastatic agent DM-COOK 158
Anthranyl derivatives having an anticholecystokinin activity (anti-CCK1), a process for their preparation, and pharmaceutical use thereof 155
Novel Anthranilic Acid Derivates with Nanomolar CCK-A Receptor Affinity 145
Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt 144
Metabolism and mechanism of the antileukemic action of isomeric aryldimethyltriazenes. 142
Synthesis of 1-aryl-3-formyl-3-methyltriazenes, potential metabolites of 1-aryl-3,3-dimethyltriazenes. 132
Synthesis of new anthranilic acid dimer derivatives and their evaluation on CCK receptors. 131
Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma. 127
Mechanism of the antimetastatic action of dimethyltriazenes. 125
Metastasis: mitostatic drugs 119
Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt 110
Synthesis and antitumor activity of hydrosoluble triazenes, analogs of DM-COOK 91
Totale 7.726
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021149 0 0 0 0 0 0 0 0 0 69 19 61
2021/2022554 10 43 20 74 10 46 19 14 63 59 44 152
2022/2023718 80 111 46 112 75 128 1 66 66 4 20 9
2023/2024331 16 14 31 22 43 6 46 95 4 6 34 14
2024/2025896 16 41 35 75 87 87 60 35 121 118 101 120
2025/20262.028 231 123 182 246 193 212 301 67 212 261 0 0
Totale 7.726